Inventor · disambiguated record
Steve Chappell Mitchell
Also filed as: MITCHELL STEVE CHAPPELL
22 granted patents·7 pending applications·184 citations·filing 2000–2010
95Inventor score
Top patents by PatentIndex Score
29 records- 0198US7507541B236P6D5: secreted tumor antigenAGENSYS INC·Filed 2007·Granted Mar 24, 2009·89 cites·26 claims
- 0291US6893818B1Gene upregulated in cancers of the prostateAGENSYS INC·Filed 2000·Granted May 17, 2005·19 cites·1 claims
- 0389US7223542B236P6D5: secreted tumor antigenAGENSYS INC·Filed 2003·Granted May 29, 2007·13 cites·2 claims
- 0488US6566078B136P6D5: secreted tumor antigenAGENSYS INC·Filed 2000·Granted May 20, 2003·12 cites·10 claims
- 0586US7771968B2Gene upregulated in cancers of the prostateAGENSYS INC·Filed 2008·Granted Aug 10, 2010·2 cites·9 claims
- 0686US7510840B1Method of inhibiting growth or survival of a cell by providing an anti-108P5H8 antibodyAGENSYS INC·Filed 2002·Granted Mar 31, 2009·16 cites·7 claims
- 0786US7459539B2Antibody that binds zinc transporter protein 108P5H8AGENSYS INC·Filed 2001·Granted Dec 2, 2008·16 cites·12 claims
- 0883US6924358B2121P1F1: a tissue specific protein highly expressed in various cancersAGENSYS INC·Filed 2001·Granted Aug 2, 2005·5 cites·4 claims
- 0974US7271240B2125P5C8: a tissue specific protein highly expressed in various cancersAGENSYS INC·Filed 2001·Granted Sep 18, 2007·2 cites·3 claims
- 1073US7928212B2Gene upregulated in cancers of the prostateAGENSYS INC·Filed 2010·Granted Apr 19, 2011·1 cites·17 claims
- 1172US6835822B1Diagnosis and therapy of cancer using SGP28-related moleculesAGENSYS INC·Filed 2000·Granted Dec 28, 2004·7 cites·6 claims
- 1271US7897740B2Secreted protein called 36P6D5 characteristic of tumorsAGENSYS INC·Filed 2009·Granted Mar 1, 2011·0 cites·19 claims
- 1370US6790631B1G protein-coupled receptor up-regulated in prostate cancer and uses thereofAGENSYS INC·Filed 2000·Granted Sep 14, 2004·1 cites·3 claims
- 1469US7834156B2125P5C8: tissue specific protein highly expressed in various cancersAGENSYS INC·Filed 2007·Granted Nov 16, 2010·0 cites·15 claims
- 1566US8013126B284P2A9: a prostate and testis specific protein highly expressed in prostate cancerAGENSYS INC·Filed 2008·Granted Sep 6, 2011·0 cites·14 claims
- 1661US7199220B2103P2D6: tissue specific protein highly expressed in various cancersAGENSYS INC·Filed 2002·Granted Apr 3, 2007·0 cites·6 claims
- 1761US7172898B2103P2D6: tissue specific protein highly expressed in various cancersAGENSYS INC·Filed 2002·Granted Feb 6, 2007·0 cites·12 claims
- 1860US2008233598A1Nucleic acid and corresponding protein entitled 121P2A3 useful in treatment and detection of cancerAGENSYS INC·Filed 2007·Application pending·0 cites
- 1959US8101372B2Diagnosis and therapy of cancer using SGP28-related moleculesHUBERT RENE S·Filed 2008·Granted Jan 24, 2012·0 cites·2 claims
- 2058US7534417B2103P2D6: tissue specific protein highly expressed in various cancersAGENSYS INC·Filed 2001·Granted May 19, 2009·0 cites·5 claims
- 2158US6838258B2G protein-coupled receptor up-regulated in prostate cancer and uses thereofAGENSYS INC·Filed 2001·Granted Jan 4, 2005·1 cites·7 claims
- 2258US2004018189A1Nucleic acid and corresponding protein entitled 121P2A3 useful in treatment and detection of cancerFiled 2002·Application pending·0 cites
- 2350US7510855B284P2A9: a prostate and testis specific protein highly expressed in prostate cancerAGENSYS INC·Filed 2001·Granted Mar 31, 2009·0 cites·4 claims
- 2447US2002150972A134P3D7: a tissue specific protein highly expressed in prostate cancerFiled 2001·Application pending·0 cites
- 2547US2002068345A198P7C3: homeodomain protein highly expressed in various cancersFiled 2001·Application pending·0 cites
- 2647US2003064418A155P4H4: gene expressed in various cancersFiled 2001·Application pending·0 cites
- 2744US7968283B2Gene expressed in prostate cancerAGENSYS INC·Filed 2010·Granted Jun 28, 2011·0 cites·5 claims
- 2842US2002055478A1GTP-binding protein useful in treatment and detection of cancerFiled 2001·Application pending·0 cites
- 2939US2002102640A183P5G4: a tissue specific protein highly expressed in prostate cancerFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →